This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Peripheral nerves and autonomic nervous system
CD2_BENIGN_PERIPH_AUTO_NEURO_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D36
- Name in latin
- Neoplasma benignum nervi peripherici
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Peripheral nerves and autonomic nervous system
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Peripheral nerves and autonomic nervous system
- Benign neoplasm of other and unspecified sites
- Benign neoplasm of other and unspecified sites
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 546 | 311 | 235 |
| Unadjusted period prevalence (%) | 0.10 | 0.11 | 0.10 |
| Median age at first event (years) | 49.09 | 48.00 | 50.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 487
- Matched controls
- 4870
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
+∞
323.0
337
*
22550
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Peripheral nerves
+∞
105.1
97
*
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
641.0
59.0
57
*
2258X
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Other specified sites of nervous system
+∞
56.3
53
*
130
Kela drug reimbursment
Malignant tumour
+∞
29.5
28
*
H02AB02
ATC
dexamethasone; systemic
22.3
28.3
41
20
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
24.2
23
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
16.8
22.7
36
23
115
Kela drug reimbursment
Breast cancer
+∞
22.0
21
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
22.0
21
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
84.0
21.9
24
*
PJA12
NOMESCO Finland
Sentinel node biopsy
229.8
21.8
22
*
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
229.8
21.8
22
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.3
21.4
48
63
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
+∞
21.0
20
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
218.9
20.7
21
*
WF002
NOMESCO Finland
Radical radiotherapy
114.9
20.7
22
*
D48.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system
+∞
18.9
18
*
2401
FHL
Nerve exploration (includes biopsy and removal of local change)
104.1
18.7
20
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
N03AX16
ATC
pregabalin; oral
2.6
17.4
154
731
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
9.7
16.4
33
36
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
165.0
15.6
16
*
N03AX12
ATC
gabapentin; oral
2.9
15.2
101
400
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
15.1
143
696
NDR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of wrist or hand
13.8
14.8
25
19
A04AA02
ATC
granisetron; systemic, transdermal
82.6
14.6
16
*
A03FA01
ATC
metoclopramide; systemic, rectal
3.0
13.9
87
330
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
+∞
13.6
13
*
116
Kela drug reimbursment
Prostate cancer
+∞
13.6
13
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.6
13
*
ACB99
NOMESCO Finland
Other operation for lesion of peripheral nerve: other or unspecified
+∞
13.6
13
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
10.9
12.9
24
23
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
7.6
12.7
29
40
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
71.8
12.6
14
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
12.5
12
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
12.5
12
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
11.7
53
158
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
66.6
11.7
13
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.3
11.6
43
107
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
122.8
11.5
12
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
122.8
11.5
12
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
122.8
11.5
12
*
Z31.5
ICD-10 Finland
Genetic counselling
5.5
11.4
33
63
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
10.9
138
757
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.8
10.6
26
40
JN4AD
NOMESCO Finland
Body CT examination
5.2
10.5
32
65
ZX090
NOMESCO Finland
Other technic of radiotherapy
112.3
10.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
112.3
10.5
11
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
10.4
10
*
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
12.4
10.4
18
15
R22.3
ICD-10 Finland
Localized swelling, mass and lump, upper limb
7.7
10.3
23
31
ZXA05
NOMESCO Finland
Left side
2.1
10.2
134
743
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
10.1
98
471
L02AE02
ATC
leuprorelin; implant, parenteral
40.9
10.0
12
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.8
9.9
32
70
JN4BD
NOMESCO Finland
Extensive body CT
4.3
9.9
36
89
D21.2
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of lower limb, including hip
20.5
9.8
14
7
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
56.1
9.7
11
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
56.1
9.7
11
*
WX110
NOMESCO Finland
Local anesthesy
1.9
9.6
324
2514
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.6
9.5
43
129
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
101.9
9.4
10
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
+∞
9.4
9
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
9.4
9
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
9.4
9
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.8
9.1
60
234
D33.30
ICD-10 Finland
Acoustic neuroma
19.0
9.0
13
7
S18
ICPC
Laceration/cut
1.8
9.0
190
1251
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
12.8
8.9
15
12
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.9
8.8
35
94
SPAT1153
SPAT
Removal of sutures
1.9
8.7
150
916
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
4.9
8.6
27
58
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
91.5
8.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
91.5
8.4
9
*
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
6.4
8.4
21
34
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
8.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
+∞
8.4
8
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
8.4
8
*
N02BE01
ATC
paracetamol; systemic, rectal
2.0
8.3
407
3487
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
5.3
8.0
23
45
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.9
7.9
21
37
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.4
7.8
22
42
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
18.7
7.6
11
6
Y77
ICPC
Malignant neoplasm prostate
81.3
7.4
8
*
ACB15
NOMESCO Finland
Excision of local lesion of tibial nerve
+∞
7.3
7
*
2312
FHL
Extirpation or destruction
+∞
7.3
7
*
ACB18
NOMESCO Finland
Excision of local lesion of brachial plexus
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
7.3
7
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.8
7.3
29
79
HAB40
NOMESCO Finland
Wedge excision of mammary gland
16.0
7.3
11
7
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.2
7.1
18
30
HA1AA
NOMESCO Finland
X-ray mammography
4.1
7.1
26
66
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.6
7.0
23
52
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.8
7.0
45
173
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.9
6.9
27
73
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
6.9
192
1351
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
40.6
6.8
8
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
17.0
6.8
10
6
WX402
NOMESCO Finland
General anaesthesia
2.2
6.7
68
333
L02BG04
ATC
letrozole; oral
12.5
6.6
11
9
R4110
NOMESCO Finland
Physiotherapy
1.8
6.6
118
721
N02AA05
ATC
oxycodone; systemic
2.3
6.5
59
272
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
70.7
6.4
7
*
TQW99
NOMESCO Finland
Other minor procedure on skin
3.8
6.4
25
68
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
8.3
6.4
13
16
ZXA00
NOMESCO Finland
Right side
1.8
6.4
127
803
A04AD12
ATC
aprepitant; systemic
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
NCR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of elbow or forearm
+∞
6.3
6
*
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
+∞
6.3
6
*
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
6.3
6
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
7.2
6.3
14
20
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
27.0
6.2
8
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.5
6.2
27
80
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.3
6.1
17
33
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.7
6.0
19
42
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.1
6.0
31
105
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
272
1787
2.04
14.81
4.0
3.6
—
—
—
0
0
27
52
5.41
13.56
1.4
1.2
—
—
—
0
0
62
220
3.05
13.56
4.1
1.5
3.6
4.1
ug/l
0.14
46
171
310
2340
1.75
9.25
8.3
6.6
4.0
4.2
e9/l
1.32
266
2058
251
1819
1.70
8.40
6.6
5.5
1.2
1.2
mmol/l
0.59
230
1634
275
2057
1.68
8.07
6.2
3.8
10.9
11.3
umol/l
0.24
260
1938
140
868
1.82
8.05
2.3
2.0
—
—
—
0
0
191
1326
1.68
7.26
3.3
2.1
2.4
2.4
mmol/l
0.05
166
1107
266
2020
1.62
7.01
6.8
6.0
1.2
1.2
mmol/l
0.93
231
1739
11
18
6.22
6.45
3.4
1.9
2.0
3.4
nmol/l
0.84
11
18
79
451
1.88
5.79
8.5
8.6
1.3
1.6
mmol/l
0.21
56
345
12
25
4.89
5.52
1.5
2.2
—
—
—
0
0
485
4410
1.89
5.30
15.7
11.9
23.4
22.3
mg/l
0.29
387
3401
224
1727
1.50
5.01
4.6
3.7
35.0
35.9
g/l
1.23
203
1604
384
3311
1.54
4.95
4.0
4.1
10.5
11.4
mm/h
0.70
350
3050
92
580
1.70
4.83
3.9
2.8
0.8
0.8
mmol/l
0.11
86
533
305
2523
1.47
4.70
5.7
4.4
6.7
6.7
mmol/l
0.02
293
2349
499
4621
1.93
4.54
18.4
14.3
139.8
139.7
mmol/l
0.43
489
4493
500
4635
1.93
4.51
18.3
14.4
3.9
4.0
mmol/l
1.67
488
4503
374
3260
1.47
4.13
8.4
5.3
73.9
75.3
u/l
0.24
354
3019
57
332
1.80
3.94
2.0
1.9
65.2
66.8
ml/min/173m2
0.10
19
134
59
356
1.74
3.63
2.7
1.9
33.2
33.3
u/l
0.00
44
300
180
1402
1.42
3.56
2.2
2.1
151.7
243.2
u/l
0.97
169
1325
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
106
2.32
3.50
2.8
3.0
0.4
0.4
u/ml
0.04
15
61
42
232
1.88
3.45
2.3
3.4
4.1
4.6
pmol/l
2.49
36
203
9
19
4.80
3.25
2.3
1.3
13.0
15.9
ug/l
—
9
19
12
38
3.21
3.23
1.9
1.2
0.1
0.4
nmol/l
—
6
31
48
284
1.76
3.17
1.3
1.4
—
42.5
—
0
15
77
518
1.57
3.12
3.7
4.9
1.0
1.0
mmol/l
0.44
71
475
87
614
1.50
2.84
1.9
1.9
29.1
29.6
s
0.39
87
596
94
677
1.47
2.77
2.6
2.6
1.0
1.2
e6/l
0.20
59
378
318
2791
1.33
2.76
5.0
4.2
985.4
3284.7
e6/l
—
5
45
5
6
8.39
2.75
2.4
2.0
—
—
—
0
0
382
3452
1.35
2.68
4.2
3.9
14.5
14.8
pmol/l
1.47
347
3137
28
150
1.91
2.56
1.4
1.2
31.8
26.5
iu/l
0.25
18
133
141
1108
1.37
2.54
3.1
2.9
0.7
0.4
e6/l
0.61
113
829
50
321
1.61
2.48
2.7
2.5
11.8
18.7
au/ml
—
5
10
446
4153
1.40
2.43
5.0
4.7
1.9
2.2
mu/l
0.48
400
3799
107
824
1.37
2.17
4.4
3.9
123.8
331.0
ng/l
1.07
84
651
7
19
3.72
2.15
1.1
1.3
—
—
—
0
0
396
3648
1.31
2.12
18.6
14.3
13.6
13.6
%
0.25
391
3573
13
56
2.35
2.06
1.2
1.3
0.5
0.6
nmol/l
1.29
13
49
62
445
1.44
1.89
2.5
2.2
9.7
7.5
umol/l
0.27
55
384
106
834
1.34
1.88
1.9
1.7
1046.9
1173.2
nmol/l
0.83
75
629
15
72
2.11
1.88
1.5
1.4
80.9
59.6
pmol/l
0.37
15
72
163
1361
1.28
1.87
2.9
2.2
68.4
57.5
u/l
0.38
151
1249
99
774
1.34
1.83
1.4
1.3
6.5
14.3
u/ml
0.71
33
310
137
1128
1.29
1.75
2.2
2.3
2771.6
6983.2
umol/l
0.82
123
977
164
1382
1.27
1.73
3.7
2.7
28.8
31.7
u/l
0.96
153
1317
209
1812
1.25
1.73
2.1
2.3
77.1
77.4
nmol/l
0.04
181
1608
7
24
2.94
1.72
1.1
1.0
—
—
—
0
0
75
568
1.37
1.70
8.2
6.6
—
—
—
0
0
81
622
1.35
1.69
2.6
2.8
3.0
2.5
e6/l
0.20
46
324
445
4208
1.31
1.68
14.9
10.7
81.7
80.6
ml/min/173m2
0.54
386
3369
15
77
1.97
1.60
1.9
1.4
—
—
—
0
0
498
4797
1.43
1.60
11.2
8.7
25.1
26.2
u/l
1.06
481
4611
101
816
1.29
1.49
1.3
1.3
32.8
36.9
iu/ml
0.10
33
256
115
945
1.27
1.48
1.8
1.7
0.9
1.1
mg/l
0.22
93
713
242
2159
1.22
1.48
4.7
4.6
0.0
0.0
estimate
0.50
45
369
138
1163
1.25
1.44
4.9
3.6
0.0
0.0
estimate
0.50
44
362
198
1742
1.21
1.37
3.5
3.5
21.4
56.1
ng/l
1.04
123
1200
514
4998
1.48
1.37
24.2
17.7
135.7
136.9
g/l
1.19
508
4916
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
17
2.96
1.36
1.0
1.2
—
—
—
0
0
321
2963
1.20
1.32
2.9
3.0
40.0
46.2
u/l
0.98
294
2763
428
4064
1.25
1.32
17.1
13.0
40.7
40.4
%
0.39
303
2920
0
41
0.00
1.31
0.0
1.0
—
—
—
0
0
43
311
1.42
1.31
2.7
1.6
66.9
67.7
g/l
0.27
38
277
14
76
1.86
1.31
1.1
1.4
—
—
—
0
0
14
76
1.86
1.31
1.1
1.4
—
—
—
0
0
239
2149
1.20
1.30
3.9
3.4
0.0
0.0
estimate
0.00
43
370
6
24
2.52
1.30
1.3
1.5
—
—
—
0
0
93
757
1.28
1.30
3.5
2.1
2.5
2.4
mmol/l
0.64
78
656
5
18
2.79
1.28
2.8
1.4
—
—
—
0
0
210
1868
1.20
1.28
2.7
2.7
131.1
117.4
ug/l
0.31
190
1721
52
391
1.36
1.27
1.9
2.0
—
—
—
0
0
5
19
2.65
1.22
1.0
1.2
—
—
—
0
0
241
2186
1.18
1.16
4.0
3.4
0.0
0.0
estimate
0.80
44
362
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
45
337
1.37
1.14
2.0
3.9
71.2
82.3
ng/l
0.64
39
299
122
1041
1.22
1.14
2.5
2.1
2.8
3.0
mg/l
0.37
103
885
10
51
1.98
1.12
4.8
2.4
13.7
13.2
%
—
10
51
16
96
1.69
1.11
1.4
1.5
—
—
—
0
0
116
990
1.22
1.08
1.2
1.3
1.6
1.8
u/ml
0.09
27
289
51
394
1.32
1.07
2.5
1.8
366.6
372.8
nmol/l
0.08
46
365
126
1087
1.21
1.05
5.1
3.5
19.9
23.8
%
2.85
71
467
55
432
1.30
1.03
2.0
2.1
—
—
—
0
0
30
215
1.42
1.00
1.0
1.0
—
—
—
0
0
9
49
1.85
0.99
1.6
1.4
—
—
—
0
0
51
400
1.30
0.98
2.1
2.6
5.8
7.5
ug/l
0.34
43
348
22
150
1.49
0.94
3.9
1.4
3.8
4.0
g/l
0.34
17
107
22
150
1.49
0.94
3.9
1.4
—
—
—
0
0
154
1367
1.18
0.94
5.2
3.6
2.3
1.9
ug/l
1.03
142
1231
35
262
1.36
0.92
1.4
1.6
—
—
—
0
0
202
1837
1.16
0.90
2.1
2.0
98.3
97.0
pmol/l
0.16
100
928
6
32
1.88
0.82
1.3
1.3
0.9
1.0
g/l
—
6
32
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
9
54
1.68
0.75
1.7
1.4
—
—
—
0
0
16
108
1.50
0.74
3.0
1.9
190.3
236.3
pmol/l
1.34
16
102
17
118
1.45
0.70
1.3
1.2
—
—
—
0
0
62
523
1.21
0.68
2.3
2.4
23.9
24.0
%
0.02
48
450
76
655
1.19
0.67
1.7
1.8
—
—
—
0
0
73
627
1.19
0.67
2.3
2.3
14.5
13.6
umol/l
0.43
63
577
10
155
0.64
0.66
2.7
1.7
—
—
—
0
0
88
769
1.17
0.66
3.5
2.5
0.7
0.7
ug/l
0.16
65
486
32
251
1.29
0.65
1.6
1.4
—
—
—
0
0
437
4243
1.15
0.63
5.7
5.9
39.2
40.0
mmol/mol
1.21
397
3955
19
138
1.39
0.63
1.0
1.1
—
—
—
0
0
458
4464
1.16
0.62
4.5
4.6
6.0
6.0
mmol/l
0.12
413
4087
22
165
1.35
0.61
2.5
2.0
—
—
—
0
0
19
139
1.38
0.61
1.0
1.1
—
—
—
0
0
68
587
1.18
0.60
24.4
24.1
1.5
1.3
inr
—
8
82
11
73
1.52
0.56
1.6
1.6
—
—
—
0
0
10
65
1.55
0.56
1.6
1.4
—
—
—
0
0
117
1065
1.13
0.51
1.5
1.5
20.6
21.2
nmol/l
0.15
93
908
12
84
1.44
0.49
2.2
1.5
—
—
—
0
0
54
468
1.17
0.47
1.9
1.8
—
—
—
0
0
70
621
1.15
0.46
1.3
1.4
—
—
—
0
0
29
238
1.23
0.45
1.6
1.6
—
—
—
0
0
180
1693
1.09
0.43
4.3
3.5
—
—
—
0
0
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
5
32
1.57
0.42
1.6
1.2
—
—
—
0
0
5
32
1.57
0.42
1.6
1.2
—
—
—
0
0
5
32
1.57
0.42
1.6
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
64
570
1.14
0.41
2.3
2.3
2.4
2.3
g/l
0.16
57
531
14
106
1.33
0.39
1.1
1.2
3.8
3.9
mmol/l
0.09
14
98
8
111
0.72
0.37
1.4
1.2
—
—
—
0
0
32
272
1.19
0.37
6.2
3.8
5.2
5.2
kpa
0.04
27
259
42
366
1.16
0.36
3.3
3.4
120.8
196.4
ng/l
1.29
37
342
11
81
1.37
0.36
1.6
1.6
—
—
—
0
0
36
310
1.17
0.36
3.6
2.5
1.2
1.2
mmol/l
0.31
26
267
53
471
1.14
0.36
1.8
1.7
—
—
—
0
0
470
4627
1.11
0.35
5.0
5.0
2.8
2.8
mmol/l
0.69
423
4281
27
228
1.19
0.34
1.3
1.3
—
—
—
0
0
17
136
1.26
0.34
1.6
1.6
—
—
—
0
0
30
256
1.18
0.34
6.6
3.8
1.8
2.0
mmol/l
0.09
20
198
6
46
1.31
0.33
1.8
1.6
—
—
—
0
0
24
203
1.19
0.30
2.4
2.1
—
—
—
0
0
7
55
1.28
0.30
1.9
1.2
377.6
364.1
pmol/l
—
7
42
130
1227
1.08
0.29
1.7
1.6
1.3
1.4
mmol/l
1.65
113
1034
7
56
1.25
0.29
1.9
1.6
—
—
—
0
0
8
109
0.73
0.29
1.4
1.2
—
9.7
—
0
10
10
76
1.32
0.28
3.1
3.3
55.2
57.5
%
—
10
76
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
25
289
0.86
0.27
1.2
1.2
184.6
106.0
iu/ml
0.46
12
128
137
1302
1.07
0.26
2.9
3.0
750.8
1217.5
ng/l
2.05
112
1089
13
158
0.82
0.24
1.2
1.4
1.1
1.2
g/l
0.27
13
150
5
38
1.32
0.23
1.2
1.4
—
—
—
0
0
45
410
1.11
0.23
4.2
2.8
—
—
—
0
0
20
172
1.17
0.22
1.5
1.7
—
182.0
—
0
10
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
285
2783
1.05
0.21
3.1
2.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
460
4549
1.07
0.21
4.4
4.5
4.8
4.7
mmol/l
1.26
418
4220
14
117
1.20
0.20
1.1
1.2
566.0
419.5
mg/l
1.59
14
107
10
80
1.25
0.20
1.1
1.2
—
—
—
0
0
6
48
1.25
0.20
1.3
1.3
—
—
—
0
0
16
136
1.18
0.20
1.7
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
100
950
1.06
0.20
1.6
1.7
468.0
14175689.4
pmol/l
0.80
82
776
6
50
1.20
0.19
2.3
3.9
—
—
—
0
0
6
51
1.18
0.19
1.2
1.5
—
—
—
0
0
12
143
0.84
0.19
1.3
1.2
—
20.5
—
0
7
79
747
1.07
0.18
1.5
1.5
—
—
—
0
0
7
61
1.15
0.17
1.3
1.1
—
—
—
0
0
13
110
1.19
0.17
1.2
1.2
—
—
—
0
0
23
205
1.13
0.17
2.3
2.3
1.5
1.2
%
0.27
23
205
7
63
1.11
0.17
2.6
1.9
—
—
—
0
0
11
130
0.84
0.16
1.3
1.5
—
—
—
0
0
6
76
0.79
0.15
1.5
1.4
—
—
—
0
0
61
577
1.06
0.15
4.1
4.7
33.2
32.2
%
0.21
39
380
10
117
0.85
0.13
1.0
2.3
11.7
12.3
mg/l
—
10
109
9
107
0.84
0.13
1.1
1.2
—
31.2
—
0
10
37
396
0.93
0.13
1.5
1.7
—
—
—
0
0
5
46
1.09
0.09
1.2
1.6
—
—
—
0
0
143
1461
0.97
0.09
3.1
3.1
7.7
7.6
mmol/l
0.13
121
1236
17
155
1.10
0.09
1.2
1.8
—
—
—
0
0
14
126
1.11
0.09
2.5
3.1
—
—
—
0
0
434
4368
0.97
0.09
4.0
4.1
1.2
1.3
mmol/l
1.02
399
4003
8
74
1.08
0.07
1.0
1.3
—
—
—
0
0
8
76
1.05
0.07
1.1
1.1
—
—
—
0
0
15
163
0.92
0.07
1.4
2.2
—
—
—
0
0
8
93
0.86
0.06
1.0
1.2
—
—
—
0
0
100
1022
0.97
0.06
4.8
3.6
1.0
1.0
kg/l
—
9
141
14
152
0.92
0.06
1.2
1.4
0.2
0.2
g/l
0.22
14
146
143
1452
0.98
0.06
3.7
4.0
5.4
8.1
mg/mmol
0.42
94
909
14
129
1.09
0.05
1.6
1.3
—
—
—
0
0
12
111
1.08
0.04
1.2
1.1
—
—
—
0
0
12
111
1.08
0.04
1.1
1.2
—
—
—
0
0
10
108
0.92
0.03
1.2
1.5
—
—
—
0
0
451
4521
0.99
0.02
4.4
4.5
1.5
1.5
mmol/l
1.61
411
4172
15
143
1.05
0.01
1.1
1.6
—
—
—
0
0
55
543
1.01
0.01
1.3
1.8
1.3
1.5
%
2.29
43
471
12
117
1.03
0.00
1.9
1.6
16210.4
11983.7
e6/l
—
7
84
7
74
0.95
0.00
3.7
5.8
361.7
385.3
umol/l
—
7
64
5
56
0.89
0.00
1.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
4.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
1.3
—
0
7
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
5
56
0.89
0.00
1.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
1.0
1.5
—
—
—
0
0
5
50
1.00
0.00
2.0
1.4
—
—
—
0
0
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
13
130
1.00
0.00
1.9
2.4
362.1
71.2
ug/min
—
7
84
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PERIPH_AUTO_NEURO_EXALLC – Benign neoplasm: Peripheral nerves and autonomic nervous system
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).